Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antibiotic resistance: current problems and prospects]

P Mazza1

  • 1Dipartimento Farmaceutico, Università di Parma.

Bollettino Chimico Farmaceutico
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by 'Rete Ematologica Pugliese'.

Annals of hematology·2022
Same author

Recovering from chronic myeloid leukemia: the patients' perspective seen through the lens of narrative medicine.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2017
Same author

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients.

Bone marrow transplantation·2016
Same author

Impact of novel agents followed by autologous hematopoietic stem cell transplantation for multiple myeloma patients aged 65 years or older: a retrospective single Institutional analysis.

Bone marrow transplantation·2015
Same author

"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese".

Leukemia research·2015
Same author

Control of Salmonella Enteritidis in turkeys using organic acids and competitive exclusion product.

Journal of applied microbiology·2014
Same journal

[Cystic fibrosis].

Bollettino chimico farmaceutico·2006
Same journal

[Biotech].

Bollettino chimico farmaceutico·2006
Same journal

Oral delivery system of insulin microspheres: effect on relative hypoglycemia of diabetic albino rats.

Bollettino chimico farmaceutico·2005
Same journal

Effect of 5-substituted benzylideneaminosalicylic acid on carrageenan-induced ulcerative colitis.

Bollettino chimico farmaceutico·2005
Same journal

Synthesis and biological evaluation of novel naphthoquinone derivatives as potential anticancer and antimicrobial agents.

Bollettino chimico farmaceutico·2005
Same journal

Behavior of cinnamoyl-isothiocyanate towards carbon, nitrogen and oxygen reagents.

Bollettino chimico farmaceutico·2005
See all related articles

The rise of antibiotic-resistant microorganisms worldwide makes infections untreatable. New antimicrobial drugs and prudent use are crucial to combat this growing public health threat.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Context:

  • Increasing global frequency and spectrum of antibiotic-resistant microorganisms.
  • Emergence of untreatable infections due to antimicrobial resistance.
  • Transmissibility of resistance among microorganisms poses future challenges.

Purpose:

  • To highlight the urgent need for new antimicrobial drugs.
  • To emphasize the importance of developing drugs with enhanced activity.
  • To advocate for overcoming existing antimicrobial resistance mechanisms.

Summary:

  • Antibiotic resistance is a rapidly escalating worldwide issue.
  • Development of novel antimicrobial agents is essential.
  • Responsible antimicrobial drug usage in human and veterinary medicine is recommended.

Related Experiment Videos

Impact:

  • Addresses the critical challenge of untreatable infections.
  • Promotes research and development of next-generation antibiotics.
  • Contributes to strategies for mitigating the antimicrobial resistance crisis.